Stand Against MIS-C (SAM)
Contribute to research for developing treatments and provide necessities for children in hospitals
MIS-C is a recently discovered illness.
It is seriously affecting children all across the United States
Children all over the United States are experiencing the effects of Multisystem Inflammatory Syndrome in Children (MIS-C). It is a newly discovered, potentially life-threatening condition.
Protecting future children from this condition and providing help for those in the hospital with MIS-C requires advancements in research and community support.
Stand Against MIS-C (SAM) is a project by the community to help children win their fights against MIS-C.
We are asking for your help and support.
Derek Kim
President and Co-Founder
Our Mission
Stand Against MIS-C (SAM) is a project by the community to help children win their fights against MIS-C.
We hope to provide comfort and resources to MIS-C patients and families while bringing greater awareness to the general public.
How your support will help
Together, we can help children fight and beat MIS-C.
Support
Hundreds of children are in hospitals or receiving treatment. You can help provide valuable necessities and comfort.
Research
There is still a lot of research to be done towards MIS-C and developing treatments. You can directly help development.
Awareness
Many parents and children are not aware of MIS-C. You can help raise awareness so children can receive proper care.
Education
Vaccine hesitancy can be tackled with education. Your support will help us spread education towards vaccination.
What you'll receive
It feels good to do good, plus you will:
Join us as a team member who is part of the leading MIS-C support communities.
Directly benefit humanity by advancing critical MIS-C research and treatment.
Become a hero who aids thousands of children fighting MIS-C!
Give the gift of health and life
MIS-C FAQs
Since mid-May 2020, CDC has been tracking case reports of multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition associated with COVID-19. CDC is working to learn more about why some children and adolescents develop MIS-C after having COVID-19 or contact with someone with COVID-19, while others do not.
As of October 1, 2020, the number of patients meeting the case definition for MIS-C in the United States surpassed 1,000. In 2021, this number surpassed 2,000 as of February 1, 3,000 as of April 1, and 4,000 as of June 2nd.
CDC investigators are assessing reported cases of MIS-C and associated health outcomes to try to learn more about specific risk factors for MIS-C, progression of the illness in children and adolescents, and how to better identify MIS-C and distinguish it from similar illnesses.
Data provided by the Centers for Disease Control and Prevention (https://www.cdc.gov/mis/cases/index.html)
